Abstract
We describe the advantages and diagnostic/prognostic significance of low-field, near-portable benchtop NMR spectrometers for the multicomponent metabolomics analysis of targeted and untargeted urinary biomarkers (≥15) in type 2 diabetes patients. Implementation of these facilities at ‘point-of-care’ clinical sites may yield valuable advantages for the sequential monitoring of diabetic and prediabetic individuals.
| Original language | English |
|---|---|
| Article number | 108554 |
| Journal | Diabetes Research and Clinical Practice |
| Volume | 171 |
| DOIs | |
| Publication status | Published - Jan 2021 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2020
Keywords
- Biomarkers
- NMR-based metabolomics
- Non-stationary benchtop 60 MHz NMR analysis
- Prediabetes
- Type 2 diabetes